Onconephrology


The field of onconephrology encompasses the broad diapason of kidney disorders that can arise in cases with cancer. Beyond cancers of the kidney, nonrenal cancers can have renal complications, and anticancer curatives, including chemotherapy, targeted anticancer agents and immunotherapy can have adverse renal goods, leading to the development of fluid, electrolyte and acid – base diseases, as well as acute kidney injury and habitual kidney complaint. Also, renal impairment can alter the excretion and metabolism of anticancer agents, challenging cure adaptation. A clearer understanding of cancers and anticancer curatives that affect the kidney is essential to ameliorate patient care and to grease the development of new, nontoxic treatments. This series of papers aims to examine the complex relationship between cancer and the kidney across the diapason of onconephrology.



 


    Related Conference of Onconephrology

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Onconephrology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in